| | | | | | | |
 | VERTEX PHARMACEUTICALS | 0.13% | 3.75% | 11.31% | 32.27% | 38.31% | 82 513 |
| REGENERON PHARMACEUTICALS, INC. | 0.07% | 2.89% | 2.96% | 18.87% | 118.96% | 79 336 |
| BIONTECH SE | 0.79% | 0.61% | -4.37% | -11.44% | 351.76% | 34 912 |
| BEIGENE, LTD. | -0.70% | -2.48% | 18.12% | 22.01% | 66.37% | 27 008 |
 | GENMAB A/S | 0.00% | -3.07% | -9.69% | 19.05% | 70.20% | 25 338 |
 | ARGENX SE | -0.75% | -2.50% | -1.23% | 46.82% | 162.40% | 20 815 |
| SAREPTA THERAPEUTICS, INC. | -1.27% | -5.63% | -5.16% | 76.34% | 2.52% | 10 788 |
| NEUROCRINE BIOSCIENCES, INC. | -0.12% | -2.79% | -9.37% | 41.08% | 4.87% | 10 407 |
| LEGEND BIOTECH CORPORATION | -2.10% | -2.80% | 5.59% | 40.71% | --.--% | 8 824 |
| ASCENDIS PHARMA A/S | 0.80% | -0.42% | 0.30% | 2.29% | -9.89% | 6 860 |
| HALOZYME THERAPEUTICS, INC. | -4.82% | -1.46% | -10.88% | 55.74% | 160.05% | 6 857 |
| KARUNA THERAPEUTICS, INC. | 0.41% | 1.54% | 0.19% | 82.57% | 97.53% | 6 765 |
 | REMEGEN CO., LTD. | -6.31% | 4.31% | 11.49% | 26.32% | --.--% | 6 004 |
| EXELIXIS, INC. | -1.36% | 4.42% | 8.92% | -1.69% | -1.74% | 5 635 |
| AKESO, INC. | -4.61% | 6.69% | 13.14% | 131.67% | --.--% | 5 479 |
| | | | | | | |
| | Gemiddelde | -1.32% | 0.20% | 2.09% | 38.84% | 88.45% | |
| | Gewogen gemiddelde per kap. | -0.35% | 0.99% | 3.70% | 27.40% | 105.88% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
